180 related articles for article (PubMed ID: 12451256)
21. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
Fiedor P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
[TBL] [Abstract][Full Text] [Related]
22. Tolerance to musculoskeletal allografts with transient lymphocyte chimerism in miniature swine.
Bourget JL; Mathes DW; Nielsen GP; Randolph MA; Tanabe YN; Ferrara VR; Wu A; Arn S; Sachs DH; Lee WP
Transplantation; 2001 Apr; 71(7):851-6. PubMed ID: 11349715
[TBL] [Abstract][Full Text] [Related]
23. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
Siemionow MZ; Klimczak A; Unal S
Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
[TBL] [Abstract][Full Text] [Related]
24. Induction of tolerance to composite tissue allograft in a rat model.
Quatra F; Lowenberg DW; Buncke HJ; Romeo OM; Brooks D; Buntic RF; Baxter-Lowe LA
Microsurgery; 2006; 26(8):573-8. PubMed ID: 17091475
[TBL] [Abstract][Full Text] [Related]
25. Extension of composite tissue allograft survival across major histocompatibility barrier under short course of anti-lymphocyte serum and cyclosporine a therapy.
Ozer K; Gurunluoglu R; Zielinski M; Izycki D; Unsal M; Siemionow M
J Reconstr Microsurg; 2003 May; 19(4):249-56. PubMed ID: 12858248
[TBL] [Abstract][Full Text] [Related]
26. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
[TBL] [Abstract][Full Text] [Related]
27. Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants.
Bozulic LD; Wen Y; Xu H; Ildstad ST
Transplantation; 2011 Apr; 91(8):908-15. PubMed ID: 21304439
[TBL] [Abstract][Full Text] [Related]
28. Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone.
Rahhal DN; Xu H; Huang WC; Wu S; Wen Y; Huang Y; Ildstad ST
Transplantation; 2009 Sep; 88(6):773-81. PubMed ID: 19920776
[TBL] [Abstract][Full Text] [Related]
29. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
[TBL] [Abstract][Full Text] [Related]
30. A new method of bone marrow transplantation leads to extension of skin allograft survival.
Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
32. Persistence of stable intragraft cell chimerism in rat liver allografts after drug-induced tolerance.
Gassel HJ; Otto C; Klein I; Steger U; Meyer D; Gassel AM; Timmermann W; Ulrichs K; Thiede A
Transplantation; 2001 Jun; 71(12):1848-52. PubMed ID: 11455268
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
34. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats.
Markus PM; Selvaggi G; Cai X; Fung JJ; Starzl TE
Cell Transplant; 1993; 2(4):345-53. PubMed ID: 8162277
[TBL] [Abstract][Full Text] [Related]
35. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
[TBL] [Abstract][Full Text] [Related]
36. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
37. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
Salom RN; Maguire JA; Hancock WW
Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival of cardiac xenografts in fully xenogeneic (mouse --> rat) bone marrow chimeras.
Mohiuddin MM; Qin Y; Qian X; Meng Y; DiSesa VJ
Ann Thorac Surg; 2001 Sep; 72(3):740-5; discussion 745-6. PubMed ID: 11565651
[TBL] [Abstract][Full Text] [Related]
40. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
Gorantla VS; Prabhune KA; Perez-Abadia G; Ildstad ST; Maldonado C; Orhun HI; Majzoub RK; Francois CG; Kakoulidis TP; Brouha PC; Anderson GL; Pidwell DJ; Breidenbach WC; Barker JH
Transplantation; 2003 Apr; 75(7):922-32. PubMed ID: 12698075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
